This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Leland Stanford Junior University, Ludwig Institute for Cancer Research Limited. Active years: 2015-2026.
Company Filing History:
1 out of 5,383 
1 out of 5,492 
1 out of 529 
Years Active: 2015-2026
Title: The Innovative Contributions of Julie Laval
Introduction
Julie Laval is a prominent inventor based in Caux, France. She has made significant strides in the field of medical diagnostics, particularly concerning inflammatory states. Her work has implications for understanding and treating various health conditions.
Latest Patents
Julie Laval holds a patent for a method for the diagnosis and/or prognosis of granulocyte-related inflammatory states. This innovative method utilizes at least one soluble receptor-binding (RBD) to identify and quantify the expression of membrane receptors on the surface of target granulocytes. This identification and quantification can occur at a specific time or over a defined time interval, facilitating the diagnosis and prognosis of inflammatory states in mammals. She has 1 patent to her name.
Career Highlights
Throughout her career, Julie has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Montpellier 2 Sciences et Techniques. Her contributions to these organizations have been instrumental in advancing research in her field.
Collaborations
Julie has collaborated with notable colleagues, including Rabindra M Tirouvanziam and Jean-Luc Battini. These partnerships have enriched her research and expanded the impact of her work.
Conclusion
Julie Laval's innovative methods in diagnosing inflammatory states highlight her significant contributions to medical science. Her work continues to pave the way for advancements in healthcare diagnostics.